You’re doing everything right — and your numbers keep climbing.

If your Type 2 treatment isn’t working the way it should, you’re not failing.

You may have LADA — an autoimmune form of diabetes that affects up to 1 in 5 adults misdiagnosed with Type 2. The free checklist below has the 10 questions to bring to your next appointment.

Linnea May Huxford holding a copy of her book, Success with LADA Diabetes, second edition

“Linnea’s words will give readers validation after a frustrating experience trying to get diagnosed.”

“Brings together lived experience and actionable guidance in a way that will help readers feel less alone and more equipped to navigate their journey.”

You were diagnosed with Type 2 as an adult.

You’ve cut carbs, exercised, and taken your medications — and your blood sugar still creeps up.

You’re a normal weight, or even slim.

You’ve lost weight without trying.

You have a personal or family history of another autoimmune condition (Hashimoto’s, lupus, celiac, RA).

Your doctor has implied — or said outright — that your numbers are your own fault.

You’re not failing. You may have been misdiagnosed.

The Basics

What is LADA — and why is it so often missed?

What is LADA diabetes?

LADA stands for Latent Autoimmune Diabetes in Adults. Like Type 1, it’s an autoimmune condition — your immune system mistakenly attacks the insulin-producing cells in your pancreas. Unlike Type 1, it develops gradually in adulthood, which is why it gets confused with Type 2.

Why is LADA so often misdiagnosed as Type 2?

LADA looks like Type 2 in its early stages. Standard A1C, fasting glucose, and oral glucose tolerance tests can’t tell the difference. The blood tests that can — an autoantibody panel and C-peptide — are rarely ordered unless someone specifically asks for them.

Why does getting the right LADA diagnosis matter?

The right diagnosis changes everything. Some Type 2 medications can actually harm the beta cells in LADA. Precision dosing of insulin can optimize health, improve A1C, and lead to better long term outcomes.

Cover of Success with LADA Diabetes, second edition, by Linnea May Huxford

If the checklist confirms what you suspected, here’s the deeper guide.

Success with LADA Diabetes, 2nd Edition, 2026. A complete roadmap to navigating LADA with confidence.

Written from one patient to another, Success with LADA Diabetes is the comprehensive guide I wish I’d had at diagnosis. Now in its expanded second edition, it covers everything from understanding the biology of LADA, to carb counting, CGMs, insulin management, exercise, mental health, hormones, and building a life you love alongside this condition.

Foreword by Dr. Stephen W. Ponder, endocrinologist and author of Sugar Surfing.

“An admirable book… valuable as an aid to both patients and medical practitioners.” — Professor R. David G. Leslie, MD, FRCP, FAoP, Blizard Institute

Portrait of Linnea May Huxford

Hi, I’m Linnea

I was diagnosed with Type 2 diabetes — and treated as Type 2 — for years before I finally got the LADA diagnosis that I should have had from the start. Years of doing everything ‘right’ and watching my numbers climb anyway. Years of thinking it was my fault.

It wasn’t. Once I had the right diagnosis, the right tests, and the right treatment, my A1C improved.

My background is in neuroscience (Mount Holyoke College). I’m not a physician — I’m something equally valuable: a patient who’s been exactly where you are, and now spends every week helping others find the answers I had to dig for. I’m the author of Success with LADA Diabetes, the host of the LADA Life Podcast, and the person behind this site and my YouTube channel.

Watch

LADA, explained on video

Videos about misdiagnosis, insulin, CGMs and living well with LADA Diabetes.

Subscribe on YouTube (opens in a new tab)

youtube.com/@LinneaMayHuxford (opens in a new tab)

Start with These

The questions I get asked most — answered.

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use. To find out more please see our Privacy Policy.